Factorial Design and Optimization of Antiepileptic Drug: Lamotrigine Cocrystals Immediate Release Tablets

R Samineni, P Aravanan, J Chimakurthy… - Journal of Positive …, 2022 - journalppw.com
Objectives: The current study goal was to come up with an immediate release (IR)
formulation for lamotrigine. Lamotrigine is a low soluble and high permeable …

[HTML][HTML] Statistical design and optimization of sustained release formulations of pravastatin

RK Gunda, PR Manchineni - Turkish Journal of Pharmaceutical …, 2020 - ncbi.nlm.nih.gov
Objectives: The objective of the current study was to formulate a sustained release (SR)
formulation for pravastatin. Pravastatin is a lipid lowering, biopharmaceutical classification …

Statistical design, formulation and evaluation of gastro retentive floating tablets for moxifloxacin using natural and semisynthetic polymers

RK Gunda, A Vijayalakshmi - Thai Journal of Pharmaceutical …, 2015 - tjps.pharm.chula.ac.th
Purpose: The objective of current study is to develop gastro retentive formulation for
Moxifloxacin using various drug release modifiers. Moxifloxacin, novel synthetic fluoro …

Formulation and in-vitro evaluation of sustained release matrix tablets of valsartan using beta-cyclodextrin

H Khan - Research Journal of Pharmaceutical Dosage Forms …, 2020 - indianjournals.com
In the presented work formulation and in-vitro evaluation was carried out for tablets
containing Valsartan as Sustained Release using HPMC and Beta-Cyclodextrin polymers by …

Assessment of Antimicrobial activity of Moxifloxacin. HCl from Gastro Retentive Formulations

RK Gunda, A Vijayalakshmi - Thai Journal of Pharmaceutical …, 2020 - tjps.pharm.chula.ac.th
Purpose: The objective of current study is to assess the antimicrobial activity of gastro
retentive formulation for Moxifloxacin. HCl and in vitro antimicrobial evaluation using cup …

Development and evaluation of losartan potassium sustained release tablet formulations

RK Gunda, PR Manchineni - World Journal of Current Medical and …, 2019 - wjcmpr.com
Objective: The purpose of the present research study was to develop sustained release (SR)
tablet formulations for Losartan Potassium using HPMCK100M as a release retardant …

[PDF][PDF] Development and Evaluation of Valsartan Sustained Release Matrix Tablets

V Rao, J Srilekha, VB Naik - crsubscription.com
Objective: The primary goal of the current study was to create and assess valsartan, an
angiotensin II receptor type 1 antagonist, sustain release matrix tablets. Formulations with …

[PDF][PDF] WORLD JOURNAL OF CURRENT MEDICAL AND PHARMACEUTICAL RESEARCH

RK Gunda, R Manchineni - Cellulose - academia.edu
Objective: The purpose of the present research study was to develop sustained release (SR)
tablet formulations for Losartan Potassium using HPMCK100M as a release retardant …

[PDF][PDF] STATISTICAL DESIGN, OPTIMISATION OF SUSTAINED RELEASE FORMULATIONS OF PRAVASTATIN PRAVASTATININ UZATILMIŞ SALIM …

RK GUNDA, PRAO MANCHINENI - academia.edu
GİRİŞ ve AMAÇ: Bu çalışmanın amacı, Biyofarmasötik Sınıflandırma Sistemi III grubunda
olan lipit düşürücü etkili Pravastatinin sürekli salım yapan formülasyonlarını geliştirmektir …